Concepedia

D. Quiroga

DQ

Statistics

Publications

5

Citations

91

H-Index

5

Active since

2003

Affiliations

Consejo Nacional de Investigaciones Científicas y Técnicas(Current)

Universidad de Buenos Aires

Instituto de Química y Fisicoquímica Biológicas

University of Southern Denmark

Cedars-Sinai Medical Center

D. Quiroga is an author at Consejo Nacional de Investigaciones Científicas y Técnicas specializing in medicine, endocrinology, and pharmacology.

Publications per year

2003–2020

5

Publications

5

Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies

Valeria Burghi, Natalia Cristina Fernández, Yamila B. Gándola et al. · PLoS ONE · 2017 · 23 citations · Full text

, , +16

Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice.

D. Quiroga, Marina C. Muñoz, Carolina Gil‐Lozano et al. · Physiological Reports · 2018 · 22 citations · Full text

, , +16

Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice

Marina C. Muñoz, Valeria Burghi, Johanna G. Miquet et al. · Peptides · 2016 · 19 citations · Full text

, , +16

Activation of AT<sub>2</sub> receptors prevents diabetic complications in female db/db mice by NO‐mediated mechanisms

Fernando P. Dominici, Luciana C. Veiras, Justin Z. Y. Shen et al. · British Journal of Pharmacology · 2020 · 14 citations · Full text

, , +17

Plasma Thrombin-Activatable Fibrinolytic Inhibitor (TAFI) among Healthy Subjects and Patients with Vascular Diseases: A Validation Study

Jasone Monasterio, Pedro Martínez Bermúdez, D. Quiroga et al. · Pathophysiology of Haemostasis and Thrombosis · 2003 · 13 citations · Full text

, , +16

1–5 of 5